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Abstract 
Cardiovascular disease (CVD) is a major cause of death among Americans. There are many 
comorbidities that exist with CVD, such as insulin-dependent diabetes, hypertension, obesity, 
and others. Mental distress such as anxiety and depression are comorbidities associated with 
CVD as well. The purpose of this study is to investigate the potential factors that could possibly 
affect mental health in CVD patients. A de-identified database obtained from United Health 
Services - Cardiology Department in Binghamton, New York included medical records of 68,647 
patients. Using Chi-Square statistical analysis, many variables were associated with anxiety and 
depression in CVD patients. These variables included gender, age, insulin-dependent diabetes, 
hypertension, cancer malignant, obesity, heart failure, coronary artery disease, and long-term use 
of antibiotic. To our knowledge, no study has investigated the combination of these factors in 
association with mental distress in CVD patients. Findings from this study will have the potential 
to contribute to better predictive ability of mental distress in CVD patients. 
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Introduction 
Cardiovascular disease (CVD) is the number one cause of death worldwide. CVD covers 
a wide array of disorders, including diseases of the cardiac muscle and of the vascular system 
supplying the heart, brain, and other vital organs. Common cardiovascular diseases are ischemic 
heart disease, stroke, and congestive heart failure (Gaziano, Reddy, Paccaud, Horton, & 
Chaturvedi, 2006). There are many comorbidities, two or more diseases that occur together, that 
exist with CVD such as insulin-dependent diabetes, hypertension, obesity and others (Eckel, 
1997; Tong & Stevenson, 2007). Psychological distress such as depression and anxiety are also 
comorbidities typically considered secondary to living with the condition (Hennekens, 
Hennekens, Hollar, & Casey, 2005; Joynt, Whellan, & O'Connor, 2003; Rozanski, Blumenthal, 
& Kaplan , 1999). Depression is typically associated with disturbances in mood, loss of interest 
or pleasure in previously enjoyed activities, and feelings of profound sadness and hopelessness. 
Anxiety is characterized by the presence of clinically significant degrees of chronic anxiety. 
Some anxiety disorders include simple phobia, social phobia, generalized anxiety disorder, panic 
disorder, obsessive-compulsive disorder, and acute stress disorder. Some of its manifestations are 
chest pain, shortness of breath, dizziness, and headaches (Ballenger, J. C., 2000). 
There are multiple factors that may affect mental health in CVD patients, including 
comorbidities and variables such as nutrient deficiency and long-term use of antibiotics. Heart 
disease patients are prescribed antibiotics for several reasons, which may potentially lead to their 
mental distress. Many studies reveal an association of Chlamydia pneumoniae infection with 
coronary artery disease, and antichlamydial antibiotics given to cardiac patients can significantly 
reduce further cardiac events, such as ischemia or myocardial infarction (Gurfinkel, Bozovich, 
Daroca, Beck, & Mautner, 1997; Andraws, Berger, & Brown, 2005)). Antibiotics are also given 
to CVD patients to prevent surgical site infection in cardiac surgery or to prevent infection from 
cardiac electrophysiologic devices (Finkelstein et al., 2002; Chua et al., 2000). There are cases 
involving the risk of malnutrition in heart patients, which could lead to psychological distress. 
Chronic cardiac failure can contribute to a malnourished state associated with myocardial 
atrophy, a term known as cardiac cachexia. This can cause malabsorption, maldigestion, 
anorexia, and hepatic and gastrointestinal congestion. Chronic cardiac failure may also lead to 
diminished fat reserves and skeletal muscle (Webb, Kiess, & Chan-Yan, 1986). There can be 
significant morphological and functional alterations of the intestine in patients with chronic heart 
failure; greater intestinal permeability and an augmented bacterial biofilm may contribute to 
chronic inflammation and malnutrition (Sandek et al., 2007).  
Cardiovascular diseases and depression are among the leading causes of the global 
disease burden, with CVDs accounting for 17.9 million deaths globally in 2015, and depression 
affecting over 300 million people worldwide. Anxiety affects many people over the world as 
well, affecting approximately 272 million people. There is a high prevalence of anxiety and 
depression in CVD patients, with approximately 15-30% of CVD patients suffering from 
depressive disorders. Depression and anxiety have been found to worsen prognosis and quality of 
life in patients with coronary artery disease, myocardial infarction, heart failure, unstable angina, 
and coronary artery bypass grafting (Allabadi et al., 2019). Mental distress adds to the burden of 
managing CVD, therefore, it is important to study the factors that may potentially lead to mental 
distress in CVD patients for better treatment in the future. Previous studies have associated heart 
disease with psychological distress, as well as linked psychological distress to nutrient 
deficiency, antibiotic use, and other comorbidities such as diabetes, cancer, etc. There are even 
limited studies that investigated the effects of nutrient deficiencies and supplement use on mental 
health in CVD patients. However, to our knowledge, no study has looked into the integration of 
environmental factors and comorbidities that associate with mental distress in CVD patients. 
 
Methods 
A de-identified database obtained from United Health Services- Cardiology Department 
in Binghamton, New York included medical records of 68,647 patients. The quasi-independent 
variables assessed included gender, age, Body Mass Index, and comorbidities such as diabetes, 
hypertension, osteoarthritis, cancer, obesity, depression, anxiety and any type of CVD.  Other 
variables analyzed were nutrient deficiencies, laboratory biomarkers (such as elevated ESR and 
CRP levels) and long-term use of antibiotics. Besides gender, age, and BMI, the quasi-
independent variables were measured dichotomously, such as presence or absence of the 
condition. The other variables were categorized; gender was categorized as male or female, and 
age was divided into 8 categories (0-10; 11-20; 21-30; 31-40; 41-50; 51-60; 61-70; over 70). The 
dependent variable was mental distress (anxiety and depression), which were both measured 
dichotomously. Chi-square statistical analysis was used to identify the relationship between 
anxiety and depression and other variables. Data analysis was performed using SPSS 25.0.  
 
Results 
There were 38,176 females and 30,467 males in the database, with the ages ranging from 
less than 10 years to over 70 years. From SPSS crosstab statistical analysis, gender, age, insulin-
dependent diabetes, hypertension, cancer malignant, obesity, heart failure, coronary artery 
disease, elevated CRP, long-term use of antibiotic, and nutrient deficiency were strong predictors 
of depression in CVD patients.  
Strong triggers of anxiety in CVD patients included gender, age, insulin-dependent 
diabetes, hypertension, osteoarthritis, cancer malignant, obesity, congenital disease of the heart, 
heart failure, cerebrovascular disease, atherosclerosis, coronary artery disease, and long-term use 









Gender 30467 38176 1155.194 3 .000* 
Age 58542 10105 2924.789 7 .000* 
Insulin Dependent Diabetes 67912 735 18.590 1 .000* 
Hypertension 19578 49069 5045.033 1 .000* 
Osteoarthritis 65923 2724 3.726 1 .054 
Cancer Malignant 68452 195 5.612 1 .018* 
Obesity 60009 8638 46.317 1 .000* 
Congenital Disease of Heart 68584 63 3.520 1 .061 
Heart Failure 66477 2170 49.637 1 .000* 
Cerebrovascular Disease 68551 96 .684 1 .408 
Atherosclerosis 68582 65 .040 1 .842 
Coronary Artery Disease 59859 8788 464.721 1 .000* 
Elevated CRP 68403 244 7.291 1 .007* 
Elevated ESR 68331 316 .771 1 .380 
Long Term Use of Antibiotic 68341 306 13.886 1 .000* 
Nutrition Deficiency 68558 89 5.882 1 .015* 
Table 1: Predictors of depression in CVD patients 






No anxiety Anxiety Pearson Chi-
Square Value 
df P-value 
Gender 30467 38176 1833.159 3 .000* 
Age 53381 15266 9592.491 7 .000* 
Insulin Dependent Diabetes 67912 735 65.067 1 .000* 
Hypertension 19578 49069 12090.314 1 .000* 
Osteoarthritis 65923 2724 56.432 1 .000* 
Cancer Malignant 68452 195 16.235 1 .000* 
Obesity 60009 8638 338.615 1 .000* 
Congenital Disease of Heart  68584 63 9.206 1 .002* 
Heart Failure 66477 2170 183.988 1 .000* 
Cerebrovascular Disease 68551 96 4.205 1 .040* 
Atherosclerosis 68582 65 4.949 1 .026* 
Coronary Artery Disease  59859 8788 1174.040 1 .000* 
Elevated CRP  68403 244 1.424 1 .233 
Elevated ESR 68331 316 .411 1 .522 
Long Term Use of Antibiotic 68341 306 22.008 1 .000* 
Nutrition Deficiency 68558 89 .936 1 .333 
Table 2: Predictors of anxiety in CVD patients 
*significant value (alpha=0.05); strong predictors of anxiety 
 
Discussion  
The purpose of the study was to investigate the lifestyle factors and comorbidities that 
may associate with anxiety and depression in CVD patients. It is conventionally known that 
patients living with comorbidities experience a decline in mental health; however little is known 
about the potential contributing factors. This study provides insight into the comorbid conditions 
that may potentially contribute to mental distress in CVD patients. 
For instance, gender has an association with mental distress. Approximately twice as 
many women than men are diagnosed with major depression and generalized anxiety disorder 
(Leach, Christensen, Mackinnon, Windsor, & Butterworth, 2008). This is believed to be 
attributed to socio-demographic factors, health and lifestyle status factors, as well as 
psychological factors. For instance, women generally earn less than men and are less well 
educated, which is associated with depression. Being unemployed is correlated with a DSM-VI 
diagnosis of major depression. (Leach, Christensen, Mackinnon, Windsor, & Butterworth, 2008). 
Additionally, poorer physical health and less physical activity in women are positive mediators 
for the gender difference in depression and anxiety. Research indicates that men exercise more 
than women, and exercise is shown to reduce levels of depression (Leach, Christensen, 
Mackinnon, Windsor, & Butterworth, 2008). Women have greater physical morbidity than men, 
and poor physical health is highly comorbid with depression. Women are also more likely than 
men to contemplate negative experiences and thought processes, resulting in higher levels and 
longer episodes of depression (Leach, Christensen, Mackinnon, Windsor, & Butterworth, 2008.  
In addition, there may be a connection between age and mental distress. Some evidence 
reveals that aging is associated with a reduction in susceptibility to anxiety and depression. 
Possible factors are decreased emotional responsiveness with age, greater emotional control and 
psychological immunization to stressful experiences (Jorm, 2000).  
A link exists between diabetes and depression. In fact, clinical and subclinical 
expressions of depression are present in over 25% of patients with type 1 or type 2 diabetes and 
have adverse effects on functioning and quality of life. Studies indicate that depression is 
associated with poor glycemic control, particularly hyperglycemia; although it is not certain what 
the exact mechanism is for causing it, this is supposedly due to mind-body, or psychosomatic 
interactions, in which there is reciprocal interaction between depression and hyperglycemia 
(Lustman et al., 2000). Anxiety is a common comorbidity of diabetes as well. Diabetes may lead 
to anxiety due to symptom-related worries, illness-progression concerns, fear of hypoglycemia, 
or even injection-phobia (Smith et al., 2012).  
Likewise, hypertension associates with psychological distress. There is a 3-fold higher 
risk of major depression in hypertensive patients. Mechanistically, the relationship between 
depression/anxiety and blood pressure is thought to be due to the hyperactivity of the 
sympathetic nervous system. Evidence shows that plasma noradrenaline, an indirect marker of 
sympathetic tone, is elevated in patients with hypertension. Therefore, poor vagal control 
potentially increases the stress responses, which leads to mental distress in hypertensive patients 
(Scalco, Scalco, Azul, & Lotufo Neto, 2005).  
Furthermore, there is a high prevalence of mental distress with osteoarthritis. For 
instance, patients with lower limb osteoarthritis suffered 2.5 times more from anxiety or 
depression than the general population. It has been shown that regardless of anatomical location, 
pain is associated with significantly high levels of anxiety and depression. However, the 
direction of causality is unknown; pain may contribute to psychological distress, or being 
distressed may cause the patient to be more aware of the pain (Axford et al., 2010).  
Cancer is a factor to be considered as well. Depression occurs in 16.8% of cancer 
patients, but only 5.8% in the general population. Similarly, generalized anxiety disorder occurs 
in 9.5% of cancer patients but only in 0.9% of the general population (Tan, Beck, Li, Lim, & 
Krishna, 2014). The symptoms of depression and personal suffering resulting from cancer have 
been attributed to the disturbances in neurotransmitters and hypothalamic-pituitary-gonadal axis 
dysregulation. Cancer’s association with mental distress are also influenced by the stress of 
having the disease itself, as the patient is confronted by repeated threats to life, is receiving 
intense treatments, is fatigued, or is experiencing pain (Massie, 2004).  
Obesity is associated with an approximately 25% increase in the odds of mood and 
anxiety disorders. Some proposed mechanisms suggest that the stigma attached to obesity, 
especially for women, could contribute to mental distress. Activity limitations due to obesity or 
obesity-related chronic illnesses may also increase the risk of these psychiatric disorders by 
reducing involvement in rewarding or pleasurable activities. Lastly, depression and obesity may 
be linked through some environmental cause such as child abuse, or a biological cause (Simon et 
al., 2006).  
Cardiovascular disease may also lead to mental distress. Depressed mood is frequently 
experienced in cardiac patients due to them perceiving their illness as threatening one’s life and 
well-being (Hare, Toukhsati, Johansson, & Jaarsma, 2014). Anxiety is common in CVD as well; 
in fact, a large proportion of depressed CVD patients suffer a comorbid anxiety disorder (Hare, 
Toukhsati, Johansson, & Jaarsma, 2014). There are many plausible mechanisms for triggering 
mental distress in CVD patients; these include alterations in the autonomic nervous system, 
platelet receptors and function, pro-inflammatory cytokines, endothelial function, and 
coagulation factors, such as fibrinogen and plasminogen activator inhibitor-1 (Hare, Toukhsati, 
Johansson, & Jaarsma, 2014). Depression and anxiety, however, can vary based on the type of 
CVD. For example, the level of depression can vary from dysthymia to grief to major depressive 
disorder (Hare, Toukhsati, Johansson, & Jaarsma, 2014). The prevalence of depression in 
patients with cardiac disease is quite variable. Mild forms of depression are found in up to two-
thirds of patients in the hospital after acute myocardial infarction and major depression is 
generally found in about 15% of CVD patients. This prevalence is over two or three times 
greater than found in the general population. It is even more prevalent in chronic heart failure 
patients, with it being over 20% more than the general population (Hare, Toukhsati, Johansson, 
& Jaarsma, 2014). However, the data analyzed in this study did not differentiate among different 
levels of anxiety and depression. It rather just looked into the presence or absence, making a 
limitation.  
Furthermore, elevated levels of C-reactive protein (CRP), a marker of inflammation, is 
linked with psychological distress, particularly depression. Studies suggest that low-grade 
systemic inflammation may contribute to the development of depression. Proinflammatory 
cytokines activate the enzyme indoleamine-2,3-dioxygenase, which lowers production of 
serotonin and raises production of kynurenic and quinolinic acids (Wium-Andersen, Ørsted, 
Nielsen, & Nordestgaard, 2013). Decreased serotonin levels are an important factor in the 
pathogenesis of depression. Increased production of kynurenic and quinolinic acids leads to 
increased release of glutamate, which decreases production of trophic factors, including brain-
derived neurotrophic factor, a factor associated with depression (Wium-Andersen, Ørsted, 
Nielsen, & Nordestgaard, 2013).  
Although very little research had been done on mental distress and use of antibiotics, 
long-term use of antimicrobial drugs has been associated with mental disturbance as well. CVD 
patients are prescribed antibiotics for several reasons including Chlamydia pneumoniae infection 
(Gurfinkel, Bozovich, Daroca, Beck, & Mautner, 1997; Andraws, Berger, & Brown, 2005), 
prevention of surgical site infections (Finkelstein et al., 2002) as well as prevention of infections 
involving cardiac electrophysiologic devices (Chua et al., 2000). Long-term antibiotic exposure 
causes changes in the microbiota, leading to psychiatric side effects (Lurie, Yang, Haynes, 
Mamtani, & Boursi, 2015). The gut microbiota has a key role in influencing the development and 
function of the nervous system through its interaction with the gut-brain axis, which integrates 
gut functions and links them to cognitive and emotional centers of the brain (Rogers, Keating, 
Young, Wong, Licinio, & Wesselingh, 2016). This connection explains high rates of comorbidity 
between gastrointestinal and psychiatric illnesses. For instance, mood disorders affect more than 
half of all patients with irritable bowel syndrome. A large population study reported that 
treatment with a single antibiotic course was associated with an increased risk for depression and 
anxiety, rising with multiple exposures (Rogers, Keating, Young, Wong, Licinio, & Wesselingh, 
2016). Nonetheless, not much is known on the specifics of antibiotics triggering mental distress, 
so further research on this is needed.  
Additionally, nutrient deficiencies add to the etiology of mental distress. There are many 
studies in which patients experience malnutrition due to chronic cardiac failure (Webb, Kiess, & 
Chan-Yan, 1986; Sandek et al., 2007) Several nutrients support mental health and brain function. 
These include vitamin A, vitamin C, vitamin E, vitamin D, omega-3 polyunsaturated acids, B 
vitamins, coenzyme Q, and minerals. Vitamins A, C, and E are antioxidants that can prevent or 
repair damage in the brain caused by oxidative stress, which has a role in cognitive impairment, 
neurodegeneration and psychiatric disorders. Vitamin D is a neurosteroid hormone that may have 
a role in depression due to its involvement in neuroimmunomodulation, regulation of 
neurotrophic factors, neuroplasticity, and brain development (Anglin, Samaan, Walter, & 
McDonald, 2013). Omega-3 polyunsaturated fatty acids are concentrated in the brain and are 
vital fatty acids for neurological development. Deficiency in omega-3 fatty acids is related to 
inflammation in the brain and a reduction in cerebral blood flow, which are linked to mental 
illness (Parletta, Milte, & Meyer, 2013). It is hypothesized that changes in brain fatty acid 
concentration, induced by chronic dietary omega-3 fatty acid deficiency, alters serotonergic and 
dopaminergic neurotransmission (Su, Huang, Chiu, & Shen, 2003). Nonetheless, studies 
demonstrate omega-3 fatty acid deficiency does affect mental health; one case showed an 
association of lower plasma levels of omega-3 polyunsaturated fatty acids with major depression 
in acute coronary syndrome patients (Frasure-Smith, Lespérance, & Julien, 2004). Vitamin B6, 
vitamin B12, and folate are important in producing neurotransmitters and lowering high 
neurotoxic levels of homocysteine, so their deficiency can impair brain function and increase 
mental health risk. Studies have reported associations of lowered B6, B12, folate and/or elevated 
homocysteine in plasma with increased cognitive decline, dementia risk, and depression (Parletta 
et al., 2013). Coenzyme Q is an antioxidant that has anti-inflammatory properties and regular use 
of CoQ significantly lowers depressive symptoms in patients. The increased production of pro-
inflammatory cytokines and resulting brain neuroinflammation from CoQ deficiency may 
therefore induce depressive symptoms (Maes et al., 2009). Additionally, low amounts of 
minerals such as zinc, selenium, chromium and others have also been associated with impacting 
mental health (Rao, Asha, Ramesh, & Rao, 2008). 
 
Conclusion 
Many variables were associated with both anxiety and depression in CVD patients. Such 
included gender, age, insulin dependent diabetes, hypertension, cancer malignant, obesity, heart 
failure, coronary artery disease, and long-term use of antibiotic. To our knowledge, this is the 
first study that investigates different comorbidities, nutritional factors, antibiotic use, and other 
variables in relation to mental health in CVD patients. Findings from this study will have the 
potential to contribute to better predictive ability of mental distress in CVD patients.  
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